First Manhattan’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Sell
2,332
-2,020
-46% -$185K ﹤0.01% 719
2025
Q4
$392K Sell
4,352
-1,735
-29% -$165K ﹤0.01% 603
2025
Q3
$601K Sell
6,087
-966
-14% -$95.7K ﹤0.01% 508
2025
Q2
$645K Sell
7,053
-324
-4% -$31.3K ﹤0.01% 490
2025
Q1
$837K Sell
7,377
-100
-1% -$10.7K ﹤0.01% 420
2024
Q4
$792K Sell
7,477
-120
-2% -$12.9K ﹤0.01% 428
2024
Q3
$822K Buy
7,597
+876
+13% +$95.6K ﹤0.01% 401
2024
Q2
$731K Buy
6,721
+80
+1% +$9.43K ﹤0.01% 405
2024
Q1
$876K Sell
6,641
-11,419
-63% -$1.43M ﹤0.01% 391
2023
Q4
$2.2M Sell
18,060
-5,785
-24% -$646K 0.01% 286
2023
Q3
$2.68M Sell
23,845
-860
-3% -$109K 0.01% 272
2023
Q2
$3.6M Sell
24,705
-1,001
-4% -$136K 0.01% 246
2023
Q1
$3.32M Buy
25,706
+1,969
+8% +$247K 0.01% 261
2022
Q4
$3.03M Buy
23,737
+3,615
+18% +$420K 0.01% 281
2022
Q3
$2.1M Sell
20,122
-927
-4% -$102K 0.01% 313
2022
Q2
$2.21M Sell
21,049
-14
-0.1% -$1.66K 0.01% 321
2022
Q1
$2.69M Buy
21,063
+4,254
+25% +$513K 0.01% 327
2021
Q4
$2.07M Sell
16,809
-892
-5% -$117K 0.01% 341
2021
Q3
$2.52M Sell
17,701
-277
-2% -$40.7K 0.01% 303
2021
Q2
$2.81M Sell
17,978
-7,861
-30% -$1.27M 0.01% 291
2021
Q1
$4.01M Sell
25,839
-131,185
-84% -$20.3M 0.02% 257
2020
Q4
$23.5M Sell
157,024
-12,464
-7% -$1.76M 0.11% 93
2020
Q3
$14.1M Sell
169,488
-8,772
-5% -$1.15M 0.07% 124
2020
Q2
$13.8M Sell
178,260
-85,056
-32% -$9.8M 0.08% 118
2020
Q1
$25.8M Sell
263,316
-2,091
-0.8% -$274K 0.17% 78
2019
Q4
$38.6M Sell
265,407
-849
-0.3% -$117K 0.19% 77
2019
Q3
$35.5M Sell
266,256
-5,756
-2% -$744K 0.2% 78
2019
Q2
$31.1M Sell
272,012
-24,483
-8% -$2.87M 0.17% 84
2019
Q1
$36.8M Sell
296,495
-2,884
-1% -$328K 0.21% 69
2018
Q4
$30.1M Sell
299,379
-77,971
-21% -$8.77M 0.19% 79
2018
Q3
$48.2M Sell
377,350
-2,646
-0.7% -$315K 0.26% 62
2018
Q2
$41.1M Sell
379,996
-9,146
-2% -$995K 0.24% 76
2018
Q1
$41.2M Sell
389,142
-18,335
-4% -$2.13M 0.23% 76
2017
Q4
$47.7M Sell
407,477
-9,558
-2% -$1.08M 0.26% 69
2017
Q3
$47.4M Sell
417,035
-113,772
-21% -$13.1M 0.27% 69
2017
Q2
$66.2M Sell
530,807
-1,644,119
-76% -$195M 0.39% 51
2017
Q1
$258M Sell
2,174,926
-152,567
-7% -$17.3M 1.53% 9
2016
Q4
$233M Sell
2,327,493
-314,838
-12% -$33.7M 1.42% 12
2016
Q3
$334M Buy
2,642,331
+23,446
+0.9% +$2.9M 2.03% 8
2016
Q2
$306M Sell
2,618,885
-37,236
-1% -$4.21M 1.88% 10
2016
Q1
$275M Buy
2,656,121
+116,319
+5% +$11.3M 1.69% 11
2015
Q4
$253M Sell
2,539,802
-66,585
-3% -$6.51M 1.55% 14
2015
Q3
$238M Buy
2,606,387
+211,847
+9% +$21.2M 1.53% 14
2015
Q2
$254M Buy
2,394,540
+365,684
+18% +$40.5M 1.5% 13
2015
Q1
$231M Buy
2,028,856
+1,459,812
+257% +$167M 1.33% 14
2014
Q4
$62.7M Buy
569,044
+81,705
+17% +$8.61M 0.35% 61
2014
Q3
$47.6M Sell
487,339
-174,353
-26% -$17.1M 0.28% 71
2014
Q2
$66.7M Buy
661,692
+641,583
+3,191% +$62.6M 0.42% 54
2014
Q1
$1.85M Sell
20,109
-619
-3% -$57K 0.01% 346
2013
Q4
$1.88M Buy
20,728
+83
+0.4% +$7.18K 0.01% 340
2013
Q3
$1.65M Sell
20,645
-35,247
-63% -$2.77M 0.01% 353
2013
Q2
$4.54M Buy
+55,892
New +$4.18M 0.03% 235

Other funds holding ZBH

First Manhattan's ZBH Position: Q1 2026 in Review

First Manhattan reduced its Zimmer Biomet (ZBH) stake by 46% in Q1 2026, selling an estimated $185K and leaving 2,332 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

First Manhattan first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $334M in Q3 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • First Manhattan held 2,332 shares of Zimmer Biomet worth $211K as of Q1 2026.
  • First Manhattan sold 2,020 Zimmer Biomet shares in Q1 2026, an estimated $185K.
  • Zimmer Biomet made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #719 holding.
  • First Manhattan first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's Zimmer Biomet position peaked at $334M in Q3 2016.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.